| Product Code: ETC12838507 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Influenza B Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Influenza B Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Influenza B Market - Industry Life Cycle |
3.4 Sweden Influenza B Market - Porter's Five Forces |
3.5 Sweden Influenza B Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Sweden Influenza B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Sweden Influenza B Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
3.8 Sweden Influenza B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Influenza B Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in awareness about the importance of influenza vaccination |
4.2.2 Rising prevalence of influenza B virus strains |
4.2.3 Government initiatives to promote influenza vaccination |
4.3 Market Restraints |
4.3.1 Seasonal nature of influenza outbreaks |
4.3.2 Limited public healthcare infrastructure and resources |
4.3.3 Vaccine supply chain challenges |
5 Sweden Influenza B Market Trends |
6 Sweden Influenza B Market, By Types |
6.1 Sweden Influenza B Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Influenza B Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Sweden Influenza B Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Baloxavir), 2021 - 2031F |
6.1.4 Sweden Influenza B Market Revenues & Volume, By Symptom Management (Pain Relievers, Antihistamines), 2021 - 2031F |
6.2 Sweden Influenza B Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Sweden Influenza B Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Sweden Influenza B Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 Sweden Influenza B Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 Sweden Influenza B Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Sweden Influenza B Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Sweden Influenza B Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Sweden Influenza B Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 Sweden Influenza B Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Sweden Influenza B Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Sweden Influenza B Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Sweden Influenza B Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Sweden Influenza B Market Import-Export Trade Statistics |
7.1 Sweden Influenza B Market Export to Major Countries |
7.2 Sweden Influenza B Market Imports from Major Countries |
8 Sweden Influenza B Market Key Performance Indicators |
8.1 Percentage of population vaccinated against influenza B |
8.2 Number of reported influenza B cases |
8.3 Rate of influenza B vaccine coverage among high-risk groups |
9 Sweden Influenza B Market - Opportunity Assessment |
9.1 Sweden Influenza B Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Sweden Influenza B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Sweden Influenza B Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
9.4 Sweden Influenza B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Influenza B Market - Competitive Landscape |
10.1 Sweden Influenza B Market Revenue Share, By Companies, 2024 |
10.2 Sweden Influenza B Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here